Page 2 - Valsartan Across News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Valsartan across. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Valsartan Across Today - Breaking & Trending Today

Combination of Sacubitril/Valsartan May Improve Heart Failure Outcomes

In patients with ejection fraction greater than 40% who were stabilized after a worsening heart failure event, use of combination sacubitril/valsartan led to greater reduction in plasma NT-proBNP levels compared with valsartan alone. ....

Robert Mentz , Journal Of The American College Cardiology , Duke University Medical Center , American College , Heart Failure , Rejection Fraction , Plasma Nt Probnp ,

Lupin Launches Sacubitril and Valsartan Combination Drug for Heart Failure Patients

Lupin Limited today announced the launch of combination drug Sacubitril and Valsartan under two brand names, Valentas and Arnipin, in India. ....

Rajeev Sibal , Lupin Limited , Lupin Launches Sacubitril , Valsartan Combination Drug , Heart Failure , Region Formulations ,

Blood Pressure Tablets - Are They Best Taken at Night

Blood pressure medications may confer a significant effect if taken at night rather than in the morning and may reduce the risk of developing cardiovascular events. ....

United States , M Janani Priya , Paresh Patel , Srinivasa Prasad , University Of Vigo , Apoorva Superspeciality Medical Centre , Administration Of Ramipril , May Cut Heart Risk , Almost Half , Large Randomised , Nighttime Dosing , Pragmatic Clinical , Stroke Risk , Antihypertensive Efficacy , Bedtime Dosing , Reducing Morning Blood Pressure , Reduce Risk , Large Randomised Study , Nocturnal Hypertension , Pragmatic Clinical Trial , Reducing Morning Blood Pressure Surge , Blood Pressure Tablets , They Best Taken , Pressure Tablets , Superspeciality Medical Centre , P Medicine At Night ,

JBCPL gets trademark assignment of HF drug Azmarda from Novartis for Rs 246 crores

Mumbai: JB Chemicals and Pharmaceuticals (JBCPL) has recently announced that the company has approved the assignment of trademark for Azmarda indicated for heart failure patients with reduced ejection. ....

Jb Chemicals Pharmaceuticals Ltd , Jb Chemicals And Pharmaceuticals , Heart Failure , Heart Failure Drug ,

Fierce Pharma Asia—Biocon, Viatris' insulin biosim launch; AstraZeneca China's deceleration; Huahai's FDA warning lift

Viatris launches two versions of its Biocon-partnered Lantus biosimilar. Growth of AstraZeneca's star China unit dropped. The FDA has lifted a warning lettering on the Chinese drug manufacturer behind a global valsartan recall three years ago. And more. ....

United States , Sanofi Lantus , Ronny Gal , Sk Group , Sk Inc , Biocon Partnered Lantus , Zhejiang Huahai Pharmaceutical , Olympus Innovation Ventures , Breakthrough Medicines , Zhejiang Huahai , Olympus Corp , Sk Group , South Korea , Drug Prices , Usfda Warning Letter , Venture Capital , Lass Action , Securities Law , Cell Manufacturing , Pharma Asia ,